| A Study to Evaluate Efficacy and Safety of HB0043 in Aadult Patients With Moderate to Severe Acne Vulgaris. (NCT07449156) | Shanghai Huaota Biopharmaceutical Co., Ltd. | 2026-03-27 |
| Phase III Clinical Study of HB0025 Combined With Chemotherapy Versus Pembrolizumab Combined With Chemotherapy for the First-Line Treatment of Advanced Squamous Non-Small Cell Lung Cancer (NCT07360132) | Shanghai Huaota Biopharmaceutical Co., Ltd. | 2026-01-15 |
| Phase III Clinical Study of HB0025 Combined With Chemotherapy Versus Tislelizumab Combined With Chemotherapy as First-Line Treatment for Advanced Nonsquamous Non-Small Cell Lung Cancer (NCT07383116) | Shanghai Huaota Biopharmaceutical Co., Ltd. | 2026-01-15 |
| A Study to Evaluate Single-dose of HB0043 in Healthy Adult Participants (NCT06999083) | Shanghai Huaota Biopharmaceutical Co., Ltd. | 2025-06-03 |
| Efficacy, Safety, and Tolerability of HB0043 in Hidradenitis Suppurativa Patients. (NCT06895499) | Shanghai Huaota Biopharmaceutical Co., Ltd. | 2025-03-19 |
| A Study to Evaluate HB0034 in Healthy Chinese Adult Participants (NCT06716151) | Shanghai Huaota Biopharmaceutical Co., Ltd. | 2024-12-06 |
| A Study to Evaluate Single-dose of HB0056 in Healthy Adult Participants (NCT06612970) | Shanghai Huaota Biopharmaceutical Co., Ltd. | 2024-11-18 |
| Long-Term Safety and Efficacy of HB0034 in Subjects With Generalized Pustular Psoriasis (NCT06477536) | Shanghai Huaota Biopharmaceutical Co., Ltd. | 2024-09-02 |
| A Study to Evaluate the Safety and Efficacy of HB0052 in Patients With Advanced Solid Tumors (NCT06992687) | Shanghai Huaota Biopharmaceutical Co., Ltd. | 2024-09-01 |
| Efficacy and Safety of HB0034 in Patients with Generalized Pustular Psoriasis (GPP) (NCT06231381) | Shanghai Huaota Biopharmaceutical Co., Ltd. | 2024-02-29 |
| A Study of HB0045 Injection in Patients With Advanced Solid Tumors (NCT06056323) | Shanghai Huaota Biopharmaceutical Co., Ltd. | 2023-07-18 |
| HB0034 in Patients With Generalized Pustular Psoriasis (GPP) (NCT05512598) | Shanghai Huaota Biopharmaceutical Co., Ltd. | 2022-11-06 |
| A Study to Evaluate Multi-dose of HB0034 in Healthy Adult Participants (NCT05460455) | Shanghai Huaota Biopharmaceutical Co., Ltd. | 2022-10-13 |
| A Study Evaluating the Safety and Efficacy of HB0028 in Subjects With Advanced Solid Tumors (NCT06223308) | Shanghai Huaota Biopharmaceutical Co., Ltd. | 2022-09-09 |
| A Study Evaluating the Safety and Efficacy of HB0036 in Subjects With Advanced Solid Tumors (NCT05417321) | Shanghai Huaota Biopharmaceutical Co., Ltd. | 2022-08-25 |
| A Study to Evaluate HB0034 in Healthy Adult Participants (NCT05064345) | Shanghai Huaota Biopharmaceutical Co., Ltd. | 2021-12-03 |